Eva-Maria Tsapakis, BSc(Hons), MBBS, MSc, MRCPsych, PhD(London), is a psychiatrist who has been the scientific director of Agios Charalampos Mental Clinic. She studied Pharmacology at King’s College in London and Medicine at the Medical School of St.George’s Hospital of London University. She served as a resident psychiatrist at University Hospital of St. George, Springfield and Maudsley & Royal Bethlem in London, while she was declared a Fellow of the Royal College of Psychiatrists of Great Britain in 2003, where she was awarded the College’s only scholarship to study abroad. She specialized in Emotional Disorders at the International Center for Bipolar Disorder under the direction and supervision of Ross Baldessarini at McLean Hospital, Harvard Medical School. Upon her return to London, she continued to serve in the British National Health System as a curator of psychiatry until assuming the scientific directorate of Agios Charalambos Clinical Mental Health in 2011. In 2003, she completed her studies in Cognitive-Behavioral Psychotherapy at the University of London (St. George’s Hospital) and in 2006 she received a Diploma in Clinical Psychopharmacology from the British Psychopharmacology Society. In 2007, she received a Master’s Degree (MSc) in Neuroscience of Emotion from Maastricht University, while in 2009, she completed her doctoral thesis at the Institute of Psychiatry of London University on Psycho-Pharmacogenetics and Psycho-Pharmacogenomics.

Mrs Tsapaki has contributed in writing several original scientific articles and a book entitled: “Schizophrenia’s Handbook”, published in 2005. Her awards include the Young Scientist Award at the 11th Winter Science Laboratory on Schizophrenia (2002), the Research Award at the 5th International Conference on Neuropsychiatry (2004), the Young Researcher Award at the 20th International Conference on Schizophrenia Research (2005) and the Award for Poster Publication at the 3rd International Conference on Brain and Behavior (2007). 

She is a member of many international organizations, such as the Royal College of Psychiatrists, London, UK (RCPsych), the World Psychiatric Association (WPA), the British Association for Psychopharmacology (BAP), the International Society for Psychiatric Genetics (ISPG), the European College of Neuro-Psychopharmacology (ECNP) and the American Psychiatric Association (APA).

Currently, she is a visiting researcher and fellow at the International Program for Bipolar Disorder at Harvard Medical School and a research associate at the Aristotle University of Thessaloniki’s First University Psychiatric Clinic.

Close Menu